EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient

Malo Journou, Marie Devaux, Nicolas Jaulin, Virginie Pichard, Mercedes Segovia, Aurélie Moreau, Johanne Le Duff, Maria Cristina Cuturi, Mickaël Guilbaud, Oumeya Adjali

Molecular Therapy Methods & Clinical Development · 2025-03 · 33 (1) · 101409

DOI: 10.1016/j.omtm.2025.101409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Methods & Clinical Development, 2025-03. Verfasst von Malo Journou und 9 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR 1089, Translational Gene Therapy for Genetic Diseases, Université de Nantes, CHU de Nantes, 44200 Nantes, France. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Conseil Régional des Pays de la Loire, Agence Nationale de la Recherche, AFM-Téléthon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno-associated virus (rAAV) vectors stand out as highly promising for in vivo gene transfer, particularly in targeting the skeletal muscle for treating muscular genetic diseases or secreting therapeutic factors. Despite the simplicity and efficacy of the established intramuscular (IM) route, it has been often associated with an immune-induced rapid loss of transgene expression, in particular in large animal models, and generally considered irreversible as a consequence of a cytotoxic elimination of transduced cells. Here, we report in a non-human primate model that transgene expression loss after IM delivery of an rAAV1 expressing an immunogenic protein is only transient, with the re-expression of the transgene lasting up to 5 years post-injection. We show that the recovery of transgene expression is due to persisting viral genomes in the injected muscles despite the detection of peripheral anti-transgene cellular immunity. Persisting genomes were observed in the presence of infiltrated mononuclear CD8 and CD4 T lymphocytes, among which we were able to detect FoxP3+ regulatory cells. This is to our knowledge the first report of a transient immune-mediated loss of gene expression in a large animal model after rAAV delivery that should shed new light on the issue of rAAV vector immunogenicity.

Schlagwörter

Stichwörter der Autor:innen

AAVTregsgene transferimmune responseimmunomodulationintramuscularnon-human primatetransitory loss

Autor:innen und Institutionen

  • INSERM UMR 1089, Translational Gene Therapy for Genetic Diseases, Université de Nantes, CHU de Nantes, 44200 Nantes, France.
  • INSERM UMR 1064, ITUN - Institut de Transplantation Urologie Nephrologie, CHU de Nantes, Center of Research in Transplantation and Immunology, Université de Nantes, 44200 Nantes, France.

Förderung

  • Conseil Régional des Pays de la Loire
  • Agence Nationale de la Recherche
  • AFM-Téléthon
  • Centre Hospitalier Universitaire de Nantes
  • Association Française contre les Myopathies
  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Journou, M., Devaux, M., Jaulin, N., Pichard, V., Segovia, M., Moreau, A., Le Duff, J., Cuturi, M. C., Guilbaud, M., & Adjali, O. (2025). Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient. Molecular Therapy Methods & Clinical Development, 33(1), 101409. https://doi.org/10.1016/j.omtm.2025.101409

Vancouver

Journou M, Devaux M, Jaulin N, Pichard V, Segovia M, Moreau A, et al. Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient. Molecular Therapy Methods & Clinical Development. 2025;33(1):101409. doi:10.1016/j.omtm.2025.101409

BibTeX
@article{Journou2025,
  author = {Journou, Malo and Devaux, Marie and Jaulin, Nicolas and Pichard, Virginie and Segovia, Mercedes and Moreau, Aurélie and Le Duff, Johanne and Cuturi, Maria Cristina and Guilbaud, Mickaël and Adjali, Oumeya},
  title = {Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient},
  journal = {Molecular Therapy Methods & Clinical Development},
  year = {2025},
  volume = {33},
  number = {1},
  pages = {101409},
  doi = {10.1016/j.omtm.2025.101409}
}
Kostenlos starten →